Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. (Q44648834)
Jump to navigation
Jump to search
scientific article published on 30 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. |
scientific article published on 30 March 2009 |
Statements
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer (English)
José Baselga
Wolfgang Eiermann
Vincente Guillem Porta
Milvia Zambetti
Dolores Sabadell
Günther Raab
Antonio Llombart Cussac
Alla Bozhok
Angel Martinez-Agulló
Marco Greco
Mikhail Byakhov
Juan Josè Lopez Lopez
Mauro Mansutti
Pinuccia Valagussa
Gianni Bonadonna